XYLOCAINE VISCOUS lidocaine (lignocaine) hydrochloride 21.4 mg/mL oral liquid (Reformulation)

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

lidocaine hydrochloride monohydrate, Quantity: 21.4 mg/mL

MAH:

Aspen Pharmacare Australia Pty Ltd

INN:

lidocaine (lignocaine) hydrochloride monohydrate

pharmaceutical_form:

Oral Liquid

composition:

Excipient Ingredients: carmellose sodium; propyl hydroxybenzoate; citric acid; purified water; sodium hydroxide; methyl hydroxybenzoate; saccharin sodium; Flavour

administration_route:

Buccal, Oral

units_in_package:

100mL

prescription_type:

(S2) Pharmacy Medicine

therapeutic_indication:

Indicated for the relief of pain and discomfort associated with:,?irritated or inflamed mucous membranes of the mouth, pharynx and upper gastrointestinal tract, e.g. post-tonsillectomy sore throat, dumping syndrome;,?introduction of instruments and catheters into the respiratory and gastrointestinal tract.

leaflet_short:

Visual Identification: Clear to almost clear slightly coloured viscous liquid; Container Type: Bottle; Container Material: LDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2013-08-14